<DOC>
	<DOC>NCT01284725</DOC>
	<brief_summary>The investigators wish to evaluate the discontinuation of maintenance immunosuppressive treatment after 2 years in patients with stable remission after a proliferative lupus nephritis. The patients will be continuing their treatment with hydroxychloroquine, possibly associated with low dose corticosteroids.</brief_summary>
	<brief_title>Weaning of Immunosuppression in Nephritis of Lupus</brief_title>
	<detailed_description>open multicenter randomized non-inferiority study, comparing 2 types of therapeutic strategies after 2 years of maintenance treatment: - Group I: Continuation of immunosuppressive therapy with MMF or AZA, with a background therapy with hydroxychloroquine, and possibly low-dose corticosteroids. - Group II: immunosuppressive treatment discontinuation, continuation of hydroxychloroquine, and possibly low-dose corticosteroids (15 mg / day).</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>At least 18yearsold patient, woman or man, Patient having a lupus according to the criteria of the ACR, Patient having presented a glomérulonéphrite lupique proliférative (class III or IV Has +/C, +/list(classify) V) first push or relapse proved by renal biopsy, Patient having received for this push a treatment of attack by steroids with strong doses and cyclophosphamide or mycophénolate mofétil, Patient in the course of treatment of interview(maintenance) by azathioprine or mycophénolate mofétil for at least 2 years, and at most for 3 years, with at the time of the inclusion, mycophénolate mofétil? 1 gram / day or azathioprine? 50 in the daytime, Patient in reply renal complete or partial (criteria of the European, secondary consensus 2) since? 12 months, Patient under Plaquenil ® since? 6 months with a hydroxychloroquinémie = 750 µg / L, Patient having accepted of participated in the study and having signed a lit(enlightened) consent. Patient presenting a severe chronic renal insufficiency (DFG estimated(esteemed) by MDRD &lt; 30 ml / min / 1.73m ²), Patient having presented an extrarenal push having required an increase of corticoids à&gt; 20 in the daytime during at least 7 days less than 6 months ago, Patient presenting a contraindication to the hydroxychloroquine, Unaffiliated patient in a national social security, Minor patient.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>